INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
February 12, 2025 17:54 ET
|
DiCello Levitt LLP
CHICAGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed in Lake County Circuit Court, Nineteenth Judicial Circuit, State of Illinois, on behalf of all persons and entities...
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
December 13, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Assertio Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASRT
February 17, 2024 10:44 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Assertio Holdings, Inc. (NASDAQ: ASRT) between March 9, 2023...
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
August 03, 2023 16:04 ET
|
Assertio Holdings, Inc.
Second Quarter Net Product Sales Increase 13% Year-Over-Year, Generates $18.6 Million in Cash Flow from Operations Acquisition Expected to be Significantly Accretive to Adjusted EPS in 2024 LAKE...